Recursion Pharmaceuticals... (RXRX)
NASDAQ: RXRX
· Real-Time Price · USD
5.79
0.15 (2.66%)
At close: Aug 15, 2025, 2:41 PM
Recursion Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -649.13M | -574.77M | -463.66M | -377.75M | -374.93M | -354.11M | -328.07M | -292.56M | -259.99M | -248.82M | -239.48M | -246.92M | -233.9M | -211.74M | -186.48M | -147.31M | -123.76M | -99.3M |
Depreciation & Amortization | 63.33M | 47.48M | 35.55M | 38.21M | 38.59M | 36.14M | 32.47M | 20.06M | 15.47M | 12.72M | 11.76M | 10.78M | 10.22M | 9.77M | 8.4M | 7.79M | 6.21M | 4.91M |
Stock-Based Compensation | 111.25M | 101.62M | 81.69M | 66.99M | 65.53M | 60.82M | 53.5M | 45.11M | 37.23M | 31.09M | 27.91M | 24.55M | 19.01M | 18.65M | 14.84M | 11.69M | 9.4M | 4.85M |
Other Working Capital | 31.47M | 21.81M | -387K | -2.84M | -57.42M | -55.36M | -42.85M | -39.61M | -41.44M | -42.39M | 103.15M | 104M | 109.98M | 116.03M | -7.95M | -10M | 23.02M | 26.61M |
Other Non-Cash Items | 38.76M | 27.48M | 45.13M | 83.98M | 119.7M | 87.54M | 58.61M | 8.51M | 10.11M | 13.1M | 11.37M | 10.09M | 8.78M | 6.14M | 4.1M | 2.91M | 2.9M | 361K |
Deferred Income Tax | n/a | n/a | n/a | -54.06M | -54.04M | -54.04M | -54.04M | 19K | n/a | n/a | n/a | n/a | 827K | 827K | 827K | 827K | 1.76M | 1.76M |
Change in Working Capital | 52.76M | 42.5M | 6.05M | -11.27M | -62.45M | -62.3M | -50.26M | -39.59M | -42.89M | -42.31M | 104.92M | 101.56M | 116.62M | 125.88M | -306K | 35.21M | 28.2M | 29.09M |
Operating Cash Flow | -383.03M | -388.83M | -359.17M | -317.82M | -331.52M | -316.76M | -287.78M | -258.45M | -240.07M | -234.23M | -83.52M | -99.93M | -78.44M | -50.47M | -158.61M | -88.88M | -75.29M | -58.34M |
Capital Expenditures | -8.19M | -9.22M | -14.04M | -14.81M | -14.08M | -13.87M | -12.55M | -18.11M | -25.85M | -38.36M | -37.36M | -33.84M | -34.99M | -24.72M | -39.8M | -39.92M | -31.05M | -25.47M |
Cash Acquisitions | 277.1M | 277.1M | 277.1M | -71K | -71K | 1.84M | 1.84M | 1.92M | 1.92M | n/a | n/a | -184.17M | -184.17M | -184.17M | -184.17M | n/a | -2.6M | -2.6M |
Purchase of Investments | 2.94M | 3.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -116.97M | -301.14M | -301.14M | -301.14M | -184.17M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 480K | 480K | 480K | 480K | 61.55M | 82.96M | 230.61M | 299.8M | 238.25M | 216.84M | 69.19M | n/a | n/a | n/a |
Other Investing Acitivies | -14.38M | -15.23M | -6.35M | -6.35M | -2.95M | 48K | -117K | -67K | 60.78M | 82.2M | 230.01M | 414.48M | 169.06M | 147.65M | n/a | -185.07M | -3.5M | -2.91M |
Investing Cash Flow | 257.82M | 259.44M | 260.06M | -17.89M | -13.67M | -11.54M | -10.23M | -15.72M | 37.61M | 44.6M | 193.25M | 148.99M | -97.87M | -109.02M | -271.74M | -224.09M | -33.65M | -27.47M |
Debt Repayment | -6.43M | -6.46M | -4.44M | -3.03M | -770K | -768K | -766K | -95K | -94K | -92K | -90K | -88K | -12.8M | -12.8M | -12.8M | -12.8M | -80K | 322K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 143.76M | 45.62M | 8.14M | 9.69M | 11.7M | 13.91M | 12.81M | 13.11M | 11.69M | 10.56M | 10.72M | 10.97M | 10.26M | 471.29M | 471.34M | 467.98M | 696.07M | 232.35M |
Financial Cash Flow | 165.29M | 330.75M | 304.12M | 374.14M | 411.44M | 152.11M | 140.13M | 206.73M | 155.3M | 154.18M | 154.34M | 10.88M | -2.55M | 458.49M | 458.54M | 464.78M | 705.6M | 242.27M |
Net Cash Flow | 57.72M | 209.64M | 208.23M | 46.25M | 66.93M | -175.23M | -156.69M | -67.68M | -47.29M | -35.75M | 263.76M | 59.94M | -178.86M | 299M | 28.18M | 151.8M | 596.66M | 156.46M |
Free Cash Flow | -391.22M | -398.06M | -373.22M | -332.63M | -345.6M | -330.63M | -300.33M | -276.56M | -265.92M | -272.58M | -120.88M | -133.78M | -113.43M | -75.19M | -198.41M | -128.81M | -106.34M | -83.8M |